Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatment of serious diseases with significant unmet medical needs in the orphan drug segment.

Upcoming event

June 20, 2024, 8.00am CEST

Webcast about Triac Trial II results

Latest presentation

Latest Report

Calendar and upcoming reports

August 22, 2024

Interim Report Q2 2024 (7:00am CEST)

September 19, 2024

Pareto Annual Healthcare Conference

November 8, 2024

Interim Report Q3 2024 (7:00am CET)

Joshua’s Story



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10